72 related articles for article (PubMed ID: 1436230)
1. Studies on the release of interleukin-1 (IL-1), tumor necrosis factor (TNF) and lysozyme from human non-adherent mononuclear cells (nMNC) in vitro after treatment with cisplatin and other biological response modifiers.
Sodhi A; Pai K
Neoplasma; 1992; 39(4):211-7. PubMed ID: 1436230
[TBL] [Abstract][Full Text] [Related]
2. Studies on the natural killer cell activity of human nonadherent mononuclear cells (nMNC) with tumor necrosis factor, interleukin-1, interferon-gamma and cisplatin.
Pai K; Sodhi A
Neoplasma; 1992; 39(6):363-7. PubMed ID: 1491726
[TBL] [Abstract][Full Text] [Related]
3. Effect of cisplatin, lipopolysaccharide, muramyl dipeptide and recombinant interferon-gamma on murine macrophages in vitro. I. Macrophage-mediated tumor cell lysis.
Geetha B; Sodhi A
Nat Immun Cell Growth Regul; 1989; 8(2):100-7. PubMed ID: 2503714
[TBL] [Abstract][Full Text] [Related]
4. Production of interleukin-1 and tumor necrosis factor by cisplatin-treated murine peritoneal macrophages.
Singh RK; Sodhi A; Singh SM
Nat Immun Cell Growth Regul; 1991; 10(2):105-16. PubMed ID: 1881399
[TBL] [Abstract][Full Text] [Related]
5. Effect of cisplatin and other biological response modifiers on the activity of lysozyme, plasminogen activator and 5' nucleotidase by murine macrophages in vitro.
Geetha B; Sodhi A
Biochem Int; 1990 Dec; 22(6):1103-14. PubMed ID: 2128598
[TBL] [Abstract][Full Text] [Related]
6. Effect of cisplatin, lipopolysaccharide, muramyl dipeptide and recombinant interferon-gamma on murine macrophages in vitro. II. Production of H2O2, O2- and interleukin-1.
Sodhi A; Geetha B
Nat Immun Cell Growth Regul; 1989; 8(2):108-16. PubMed ID: 2548090
[TBL] [Abstract][Full Text] [Related]
7. Increased production of interleukin-1 and tumor necrosis factor by human monocytes treated in vitro with cisplatin or other biological response modifiers.
Sodhi A; Pai K
Immunol Lett; 1992 Dec; 34(3):183-8. PubMed ID: 1487305
[TBL] [Abstract][Full Text] [Related]
8. Studies on the intracellular Ca2+, protein kinase activity, and ATP contents of cisplatin- and rIFN-Y-treated non-adherent mononuclear cells.
Pai K; Sodhi A
Biochem Int; 1992 May; 26(6):1017-24. PubMed ID: 1632798
[TBL] [Abstract][Full Text] [Related]
9. Effect of cisplatin, rIFN-Y, LPS and MDP on release of H2O2, O2- and lysozyme from human monocytes in vitro.
Pai K; Sodhi A
Indian J Exp Biol; 1991 Oct; 29(10):910-5. PubMed ID: 1667647
[TBL] [Abstract][Full Text] [Related]
10. Induction of membrane-associated interleukin 1 alpha (IL-1 alpha) by synergistic activation of human blood monocytes with interferon gamma and muramyl dipeptide analog.
Okubo A; Sone S; Tanaka M; Fukuta K; Inamura N; Nakanishi M; Maeda K; Yanagawa H; Nishioka Y; Yamashita C
Tokushima J Exp Med; 1989 Dec; 36(3-4):97-105. PubMed ID: 2484023
[TBL] [Abstract][Full Text] [Related]
11. The incubation of human blood monocytes with tumor necrosis factor-alpha leads to lysis of tumor necrosis factor-sensitive but not resistant tumor cells.
Nii A; Fidler IJ
Lymphokine Res; 1990; 9(2):113-24. PubMed ID: 2338840
[TBL] [Abstract][Full Text] [Related]
12. [The stimulating action of lipopolysaccharide and muramyl dipeptide on the activation of mononuclear cells in human peripheral blood by recombinant interleukin-2 in vitro].
Rakhmilevich AL; Pelevina MA; Artsimovich NG; Fuks BB
Biull Eksp Biol Med; 1988 Dec; 106(12):698-701. PubMed ID: 3061497
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of LPS, IFN-gamma and TNF alpha on the secretion of lysozyme by individual human mononuclear phagocytes: relationship to cell maturity.
Lewis CE; McCarthy SP; Lorenzen J; McGee JO
Immunology; 1990 Mar; 69(3):402-8. PubMed ID: 2107146
[TBL] [Abstract][Full Text] [Related]
14. Modulation of lipopolysaccharide-induced cytokine gene expression in mouse bone marrow-derived macrophages by muramyl dipeptide.
Le Contel C; Temime N; Charron DJ; Parant MA
J Immunol; 1993 May; 150(10):4541-9. PubMed ID: 8482846
[TBL] [Abstract][Full Text] [Related]
15. Activation of human peripheral-blood-derived monocytes by cis-diamminedichloroplatinum: enhanced tumoricidal activity and secretion of tumor necrosis factor-alpha.
Gan XH; Jewett A; Bonavida B
Nat Immun; 1992; 11(3):144-55. PubMed ID: 1392402
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of tumour necrosis factor production and sensitivity to interleukin-2 of human peripheral blood mononuclear cells stimulated by lipopolysaccharide and muramyl dipeptide in vitro.
Rakhmilevich AL; Shneiderova MA; Korobko VG; Chuvpilo SA
Biomed Sci; 1990; 1(5):517-23. PubMed ID: 2133069
[TBL] [Abstract][Full Text] [Related]
17. Initial characterization of a lymphokine pathway for the immunologic induction of tumor necrosis factor-alpha release from human peripheral blood mononuclear cells.
Kornbluth RS; Gregory SA; Edgington TS
J Immunol; 1988 Sep; 141(6):2006-15. PubMed ID: 3139748
[TBL] [Abstract][Full Text] [Related]
18. IFN-gamma and LPS overcome glucocorticoid inhibition of priming for superoxide release in human monocytes. Evidence that secretion of IL-1 and tumor necrosis factor-alpha is not essential for monocyte priming.
Szefler SJ; Norton CE; Ball B; Gross JM; Aida Y; Pabst MJ
J Immunol; 1989 Jun; 142(11):3985-92. PubMed ID: 2541203
[TBL] [Abstract][Full Text] [Related]
19. Tumor targets stimulate IL-2 activated killer cells to produce interferon-gamma and tumor necrosis factor.
Chong AS; Scuderi P; Grimes WJ; Hersh EM
J Immunol; 1989 Mar; 142(6):2133-9. PubMed ID: 2493506
[TBL] [Abstract][Full Text] [Related]
20. Activation of human natural killer cells by lipopolysaccharide and generation of interleukin-1 alpha, beta, tumour necrosis factor and interleukin-6. Effect of IL-1 receptor antagonist.
Conti P; Dempsey RA; Reale M; Barbacane RC; Panara MR; Bongrazio M; Mier JW
Immunology; 1991 Aug; 73(4):450-6. PubMed ID: 1833315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
